Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/172122
Title: | 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary |
Author: | Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. Cruz Merino, L. de la Concha, Ángel Balaña, Carmen Matias-Guiu, Xavier |
Keywords: | Càncer Metàstasi Cancer Metastasis |
Issue Date: | 1-Nov-2018 |
Publisher: | Springer International Publishing Ag |
Abstract: | Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2-9% of all cancer patients, mostly 60-75years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed. |
Note: | Reproducció del document publicat a: https://doi.org/10.1007/s12094-018-1899-z |
It is part of: | Clinical & Translational Oncology, 2018, vol. 20, num. 11, p. 1361-1372 |
URI: | http://hdl.handle.net/2445/172122 |
Related resource: | https://doi.org/10.1007/s12094-018-1899-z |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
This item is licensed under a
Creative Commons License